Combined NO and PG inhibition augments α-adrenergic vasoconstriction in contracting human skeletal muscle
- 1 December 2004
- journal article
- clinical trial
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 287 (6) , H2576-H2584
- https://doi.org/10.1152/ajpheart.00621.2004
Abstract
Sympathetic α-adrenergic vasoconstrictor responses are blunted in the vascular beds of contracting muscle (functional sympatholysis). We tested the hypothesis that combined inhibition of nitric oxide (NO) and prostaglandins (PGs) restores sympathetic vasoconstriction in contracting human muscle. We measured forearm blood flow via Doppler ultrasound and calculated the reduction in forearm vascular conductance in response to α-adrenergic receptor stimulation during rhythmic handgrip exercise (6.4 kg) and during a control nonexercise vasodilator condition (using intra-arterial adenosine) before and after combined local inhibition of NO synthase (NOS; via N G-nitro-l-arginine methyl ester) and cyclooxygenase (via ketorolac) in healthy men. Before combined inhibition of NO and PGs, the forearm vasoconstrictor responses to intra-arterial tyramine (which evoked endogenous noradrenaline release), phenylephrine (a selective α1-agonist), and clonidine (an α2-agonist) were significantly blunted during exercise compared with adenosine treatment. After combined inhibition of NO and PGs, the vasoconstrictor responses to all α-adrenergic receptor stimuli were augmented by ∼10% in contracting muscle ( P < 0.05), whereas the responses to phenylephrine and clonidine were also augmented by ∼10% during passive vasodilation in resting muscle ( P < 0.05). In six additional subjects, PG inhibition alone did not alter the vasoconstrictor responses in resting or contracting muscles. Thus in light of our previous findings, it appears that inhibition of either NO or PGs alone does not affect functional sympatholysis in healthy humans. However, the results from the present study indicate that combined inhibition of NO and PGs augments α-adrenergic vasoconstriction in contracting muscle but does not completely restore the vasoconstrictor responses compared with those observed during passive vasodilation in resting muscle.Keywords
This publication has 58 references indexed in Scilit:
- Blunted Sympathetic Vasoconstriction in Contracting Skeletal Muscle of Healthy Humans: is Nitric Oxide Obligatory?The Journal of Physiology, 2003
- Interaction between sympathetic nerve activation and muscle fibre contraction in resistance vessels of hamster retractor muscleThe Journal of Physiology, 2003
- Augmented leg vasoconstriction in dynamically exercising older men during acute sympathetic stimulationThe Journal of Physiology, 2003
- α1- and α2-adrenergic vasoconstriction is blunted in contracting human muscleThe Journal of Physiology, 2003
- Skeletal muscle blood flow in humans and its regulation during exerciseActa Physiologica Scandinavica, 1998
- ATP-sensitive potassium channels mediate contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle.Journal of Clinical Investigation, 1997
- NEURAL CONTROL OF MUSCLE BLOOD FLOW: IMPORTANCE DURING DYNAMIC EXERCISEClinical and Experimental Pharmacology and Physiology, 1997
- Cyclooxygenase Inhibition Restores Nitric Oxide Activity in Essential HypertensionHypertension, 1997
- Influence of prostaglandins on vasoconstrictor responses in the hindquarters vascular bed of the catProstaglandins and Medicine, 1981
- Blood Pressure during Supine Exercise in Idiopathic Orthostatic HypotensionCirculation, 1961